LncRNA PLAC 2 Is Downregulated in Osteosarcoma and Regulates Cancer Cell Proliferation Through miR-93
Authors Sun X, Yu L, Shi Y, Guo W
Received 12 November 2019
Accepted for publication 14 April 2020
Published 20 May 2020 Volume 2020:12 Pages 3623—3629
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Editor who approved publication: Dr Seema Singh
Xiangran Sun, Ling Yu, Yubo Shi, Weichun Guo
Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, People’s Republic of China
Correspondence: Weichun Guo
Department of Orthopedics, Renmin Hospital of Wuhan University, Hubei Zhang Road Wuchang District No. 99 Jiefang Road 238, Wuhan 430060, Hubei Province, People’s Republic of China
Introduction: PLAC 2 is a tumor-suppressive lncRNA in glioma, while its roles in other types of cancer remain unclear. This study was carried out to explore the potential involvement of PLAC 2 in osteosarcoma (OS).
Methods: Expression levels of PLAC 2 in OS and paired non-tumor tissues from OS patients were determined by RT-qPCR. A follow-up study was performed to analyze the prognostic value of PLAC 2 for OS. Interactions between PLAC 2 and miR-93 were assessed by cell transfection, followed by RT-qPCR. Cell proliferation assay was performed to analyze cell proliferation.
Results: Our results showed that PLAC 2 was downregulated in OS tissues, and the high expression levels of PLAC 2 were associated with favorable overall survival of OS patients. MiR-93 was upregulated in OS tissues and its expression was inversely correlated with the expression of PLAC 2. In OS cells, overexpression of PLAC 2 resulted in downregulated miR-93, while overexpression of miR-93 did not affect the expression of PLAC 2. Overexpression of PLAC 2 led to decreased proliferation rate of OS cells, while overexpression of miR-93 showed opposite roles and reduced the overexpressing effects of PLAC 2.
Conclusion: PLAC 2 is downregulated in OS and regulates cancer cell proliferation through miR-93.
Keywords: osteosarcoma, PLAC 2, miR-93, survival, proliferation
Erratum for this paper has been published
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]